"Peptide Fragments" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques.
| Descriptor ID |
D010446
|
| MeSH Number(s) |
D12.644.541
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Peptide Fragments".
Below are MeSH descriptors whose meaning is more specific than "Peptide Fragments".
This graph shows the total number of publications written about "Peptide Fragments" by people in this website by year, and whether "Peptide Fragments" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 7 | 3 | 10 |
| 1997 | 2 | 5 | 7 |
| 1998 | 9 | 7 | 16 |
| 1999 | 6 | 7 | 13 |
| 2000 | 10 | 4 | 14 |
| 2001 | 9 | 6 | 15 |
| 2002 | 12 | 17 | 29 |
| 2003 | 9 | 9 | 18 |
| 2004 | 9 | 6 | 15 |
| 2005 | 9 | 6 | 15 |
| 2006 | 4 | 6 | 10 |
| 2007 | 6 | 3 | 9 |
| 2008 | 3 | 6 | 9 |
| 2009 | 4 | 14 | 18 |
| 2010 | 3 | 12 | 15 |
| 2011 | 4 | 7 | 11 |
| 2012 | 11 | 9 | 20 |
| 2013 | 2 | 5 | 7 |
| 2014 | 4 | 4 | 8 |
| 2015 | 1 | 4 | 5 |
| 2016 | 3 | 2 | 5 |
| 2017 | 3 | 5 | 8 |
| 2018 | 3 | 3 | 6 |
| 2019 | 3 | 7 | 10 |
| 2020 | 3 | 4 | 7 |
| 2021 | 4 | 2 | 6 |
| 2022 | 0 | 7 | 7 |
| 2023 | 1 | 2 | 3 |
| 2024 | 3 | 0 | 3 |
| 2025 | 1 | 7 | 8 |
| 2026 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Peptide Fragments" by people in Profiles.
-
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia. Clin Cancer Res. 2026 Jul 17; 32(14):3018-3030.
-
Differential Biventricular Strain Recovery With Selective Fibrosis Biomarker Regression After Sleeve Gastrectomy: A Prospective CMR Feature-Tracking Study. Obes Surg. 2026 Aug; 36(8):4368-4377.
-
Relationships of CSF biomarkers to cortical atrophy in early-onset Alzheimer's disease. Alzheimers Dement. 2026 Jul; 22(7):e71479.
-
Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial. JAMA Cardiol. 2026 05 01; 11(5):446-454.
-
Blood-based AT(N) biomarkers for Alzheimer's disease and frontotemporal lobar degeneration in Latin America. Nat Aging. 2026 Feb; 6(2):430-444.
-
Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial. Circulation. 2026 Jan 27; 153(4):214-225.
-
Epicardial Adipose Tissue in Duchenne Muscular Dystrophy Cardiomyopathy. J Am Heart Assoc. 2025 10 21; 14(20):e042300.
-
Poor olfaction and risk of heart failure in the Atherosclerosis Risk in Communities Study. J Gerontol A Biol Sci Med Sci. 2025 10 05; 80(11).
-
Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia. Nat Rev Clin Oncol. 2025 Nov; 22(11):847-868.
-
NT-pro Brain Natriuretic Peptide in Infants with Single Ventricle Heart Disease in the CHAMP® Multi-site Registry. Pediatr Cardiol. 2026 Jun; 47(5):2095-2103.